Kurma Partners — Full Portfolio

BliNK Biomedical develops treatments and therapeutics in the biopharmaceutical industry.

BiotechDeep TechMedical DevicesMarseille, FR

Jack Elands(CEO & Chairman)

Co-investorsIdinvest Partners

Brink Therapeutics is a TechBio company developing programmable integrases, a nuclease-free platform for precise, large-payload genomic insertion of therapeutic genes for cell and gene therapy.

AI & Machine LearningBiotechDeep TechParis, FR

Jonathan Naccache(Co-founder (Directeur de la publication))in

Co-investorsKima VenturesBreega

Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity.

BiotechDigital HealthHealthtechLongevity

Philip JaniakMarie-Laure OzouxRégis OlivierFrancesca C. LawsonMark KowalaEleonore Jouanny

Co-investorsFountain Healthcare PartnersJeito CapitalOrbiMedV-Bio VenturesOmnes CapitalInvivo Capital Partners+1 more

Damae Medical develops deepLive, a non-invasive skin imaging system based on LC-OCT (Line-field Confocal Optical Coherence Tomography) that produces 3D histology-like and confocal-like images of skin tissue.

Deep TechDigital HealthMedical Devices

Anaïs Barut(Co-founder & CEO)David Siret(Co-founder & CTO)Arnaud Dubois(Co-founder & CSO)

Co-investorsParis-Saclay Seed FundIdinvest PartnersPartech Ventures

Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases.

BiotechMedical DevicesZurich, CH

Co-investorsPureos BioventuresYsios CapitalAdjuvant CapitalFresenius Medical Care VenturesVerve Venturesredalpine

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesSingapore, SG

Brian Burke(Co-Founder and Advisor)Mark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)Monica Shah(Chief Medical Officer)Al Gianchetti(Chief Executive Officer)

Co-investorsAngelini VenturesBoehringer Ingelheim Venture FundClavystBioHighlight CapitalSEEDS Capital

SciRhom is a biotech company developing first-in-class humanized antibodies against iRhom2, which regulates the enzyme TACE/ADAM17 to block pro-inflammatory signaling pathways.

BiotechDeep TechHealthtechMartinsried, DE

Dr. Jens Ruhe(Co-founder, Managing Director & Chief Operating Officer)Dr. Matthias Schneider(Co-founder & Chief Scientific Officer)Dr. Jan Poth(Managing Director, Chief Executive Officer)Dr. Jürgen Reeß(Chief Medical Officer)

Co-investorsAndera PartnersHadean Ventures

Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.

BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR

Alain Fischer(Founding Scientist)

Co-investorsHadean VenturesBpifrancePontifax Venture CapitalSunstone CapitalV-Bio Ventures

Synendos is a biotech company developing selective endocannabinoid reuptake inhibitors targeting the endocannabinoid system to treat neuropsychiatric disorders.

BiotechDeep TechDigital HealthMental HealthBasel, CH

Prof. Jürg Gertsch(Founder)Dr. Andrea Chicca(Co-Founder & Chief Executive Officer)Dr. Simon Russell(Co-Founder & Chief Commercial Officer)

Co-investorsYsios CapitalSunstone Capital

Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.

BiotechDeep TechMedical DevicesBerlin, DE

Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)

Co-investorsCreathor VenturesBoehringer Ingelheim Venture FundcoparionThuja Capital

Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Luc Dochez(Chair and Founder)Josh Mandel-Brehm(Co-Founder)

Co-investorsDroia VenturesPureos BioventuresEQT Life SciencesSeroba Life SciencesEurazeoIdinvest Partners

Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis.

BiotechHealthtechParis, FR

Co-investorsHealthCapNovartis Venture FundRoche Venture FundYsios CapitalColumbus Venture PartnersEurazeo+1 more

Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.

BiotechHealthtechMedical Devices

Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in

Co-investorsaMoonRA CapitalBpifranceAndera PartnersAngelini VenturesPontifax Venture Capital+1 more

A digital agency that designs and builds websites and web applications, including HTML invitations with form-based response management and help desk applications.

Marketing TechSaaS

Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.

BiotechHealthtechLongevityPhiladelphia, US

Raj Kannan(Executive Officer, Director)

BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)

Co-investorsAndera PartnersAvego BioScience CapitalGlobal BioAccess FundJeito CapitalNew Rhein Healthcare Investors, LLCSeroba Life Sciences+2 more

Alveus Pharmaceuticals offers pharmaceutical development and manufacturing services, including analytical development, product formulation, quality and regulatory support, and process validation, aligned with the relevant phase of drug development.

BiotechHealthtech

AM-Pharma develops ilofotase alfa, a recombinant alkaline phosphatase enzyme therapy, and is studying it as a treatment for adults with hypophosphatasia (HPP), a rare inherited metabolic bone disease.

BiotechHealthtech

Co-investorsAndera PartnersYsios Capital

Co-investorsAndera PartnersCTI Life Sciences Fund L.P.EQT Life SciencesLSP (Life Sciences Partners)Sofinnova Partners

Co-investorsNewfund Capital

Co-investorsM VenturesSofinnova PartnersSR One Capital Management

Co-investorsSofinnova Ventures

Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.

AI & Machine LearningBiotech

Co-investorsBioGeneration VenturesEQT Life SciencesBOMCurie CapitalV-Bio Ventures

Axithra develops a photonics-based device using Raman spectroscopy on a chip to measure the free, active fraction of drugs in patient blood for bedside therapeutic drug monitoring.

Deep TechHealthtechMedical Devices

Co-investorsQbic FundWhite Fundimec.xpandWallonie Entreprendre

BioSerenity develops and manufactures CE- and FDA-approved electrophysiological medical devices, AI, and software to capture and analyze EEG, ECG, and PSG signals for diagnosing neurological and cardiac disorders.

AI & Machine LearningDigital HealthMedical DevicesTroyes, FR

Co-investorsJolt Capital

Kiro is a CE-marked medical device application that centralizes patients' biological and medical test results, providing personalized explanations and health timelines to help people understand and track their lab results.

AI & Machine LearningDigital HealthHealthtech

Cardiologs develops software that uses clinically validated AI and cloud technology to analyze ECGs and support cardiology diagnostics.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsIsaiISAI GestionParis-Saclay Seed Fund

Charles is a French telehealth platform offering online medical consultations and personalized treatment for conditions such as sexual health, weight loss, and hair loss.

Digital HealthHealthtechWellness & Fitness

Co-investorsAccelDTCCHV CapitalInkefSalesforce Ventures

Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.

BiotechDeep TechHealthtechMedical DevicesParis, FR

Co-investorsFund+Seroba Life SciencesV-Bio VenturesBpifranceInvusNovo Holdings+1 more

DNA Script develops enzymatic DNA synthesis technology, offered through its SYNTAX platform, that lets labs produce high-quality ssDNA oligos in-house and overnight.

BiotechDeep TechHardwareParis, FR

Thomas Ybert(Founder)in

Co-investorsCoatue ManagementM Ventures

Elkedonia is a biotech company developing a novel antidepressant treatment that targets intracellular neuroplasticity pathways rather than synaptic mechanisms, with the goal of providing rapid, long-lasting relief for depression patients.

BiotechDigital HealthMental Health

Delphine Charvin(Founding Chief Executive Officer & Board Director)Mélanie Rouillier(VP, Chief Operations Officer & Co-Founder)Jocelyne Caboche(President of the Scientific Advisory Board & Co-Founder)

Co-investorsAngelini VenturesCARMA FUND

Co-investorsPontifax Venture Capital

EVL Bio is developing a selective anti-FGFR4 monoclonal antibody therapy to treat left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD).

BiotechDigital HealthLongevity

Co-investorsAdBio partners

Co-investorsCathay HealthCAP HORN VC

Germitec develops UV-C technology-based disinfection systems for high-level decontamination of ultrasound probes and other medical devices used in healthcare settings.

Deep TechHardwareHealthtechMedical DevicesNot stated, FR

Clément Deshays

Co-investorsEuropean Investment BankEurazeo

Sunrise offers a 3-gram home sensor that provides overnight results to diagnose sleep apnea, connecting users with sleep specialists for personalized medical follow-up.

Digital HealthHealthtechMedical Devices

Hopia is an AI platform that automates staff scheduling for doctors and caregivers across all hospital departments, using a proprietary symbolic AI to model legal, collective, and individual rules.

AI & Machine LearningDigital HealthSaaS

Co-investorsIris Capital

ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.

BiotechHealthtech

Co-investorsAndera PartnersPfizer Venture InvestmentsPureos BioventuresAgent CapitalGimv

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

BiotechMedical Devices

Dr. Dhingra

Co-investorsAvoro Capital AdvisorsEIR VenturesRA CapitalSamsara BioCapitalSunstone CapitalVivo Capital+2 more

Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.

BiotechHealthtech

Co-investorsAngelini VenturesCurie Capital

Co-investorsAndera PartnersSeroba Life SciencesVI PartnersYsios Capital

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops.

AgTechBiotechDeep Tech

Ricardo Garcia de Albain

Co-investorsGenoa VenturesSofinnova PartnersCasdin Capital

Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.

BiotechDeep TechHealthtechMedical DevicesMataró, ES

Marc Martinell(Co-Founder & Chief Executive Officer)

Co-investorsChiesi VenturesCriteria Bio VenturesFund+Invivo Capital PartnersRoche Venture FundYsios Capital+1 more

NAOX Technologies develops in-ear EEG technology to bring brain monitoring out of the lab and into everyday life.

HardwareHealthtechMedical Devices

Nuclidium is a clinical-stage biotechnology company developing copper-based radiopharmaceuticals for cancer diagnosis and treatment, using Copper-61 for diagnostics and Copper-67 for therapeutics.

BiotechHealthtechMedical DevicesBasel, CH

Co-investorsAngelini VenturesDeepTech & Climate FondsNeva Sgr.VIVES Partners

Omnidoc provides a medical collaboration platform for healthcare professionals and organizations, offering telexpertise (remote specialist advice), e-RCP (multidisciplinary team meetings), and assisted teleconsultation.

Digital HealthHealthtechSaaSParis, FR

Baptiste Truchot(Founder)in

Co-investorsNewfund CapitalAlven

PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.

BiotechDeep TechHealthtechMedical DevicesMol, BE

Sven van den berghe(CEO)Christophe Malice(CBO)Samy Bertrand(CTO)Yves Sterckx(Director of Finance & Administration)Philippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)

Co-investorsEQT Life SciencesKorysLSP (Life Sciences Partners)PMV

PathoQuest develops iDTECT, a platform of Next Generation Sequencing (NGS) assays for biopharmaceutical quality control, offering animal-free viral safety testing and genetic characterization of cell banks and biologics.

BiotechDeep TechHealthtechMedical DevicesParis, FR

Marc Eloit(Founder and Scientific Advisor)

Co-investorsVerve Ventures

Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema.

BiotechHealthtech

Co-investorsBain Capital Life SciencesForesite CapitalvenBio Partners

Poppins operates a peer-to-peer rental marketplace where individuals, professionals, and local shops in the same neighborhood lend and rent everyday objects, with booking, owner messaging, and a guarantee system handled in one app.

Circular EconomyConsumerMarketplaces

Co-investorsAFI VenturesKima VenturesBNP Paribas DéveloppementEurazeoVerve Ventures

Poppins is a clinically validated digital medical device for children aged 7-11 with dyslexia and reading difficulties.

AI & Machine LearningDigital HealthEdTechHealthtechParis, FR

Co-investorsTechstarsVerve Ventures

Raidium develops an AI-native PACS viewer built on a foundation model for radiology, unifying image-viewing and diagnostic tasks in a single promptable platform.

AI & Machine LearningDigital HealthMedical Devices

Paul Herent, M.D., Msc(Founder)in

Co-investorsDebiopharm Innovation FundGalion.exeNewfund CapitalFounders FutureStartX

Recept AI provides an AI-powered virtual receptionist/tele-secretary service for dental practices, handling incoming calls, appointment booking, cancellations, reminders and patient record management 24/7.

AI & Machine LearningDigital HealthSaaS

RyCarma Therapeutics develops a novel drug class called Rycals to treat orphan skeletal muscle and cardiac diseases, building on foundational cardiovascular research and drug-delivery technologies.

BiotechHealthtechMedical DevicesNew York, US

Andrew R. Marks(Founding Scientist, MD)

Co-investorsPontifax Venture Capital

Sensome develops medical technology solutions at the intersection of engineering and life sciences, focusing on healthcare applications.

Deep TechHealthtechMedical Devices

Co-investorsParis-Saclay Seed FundBNP Paribas DéveloppementIdinvest Partners

Shorla Oncology develops pharmaceutical products to address unmet needs in oncology.

BiotechHealthtechMedical DevicesDublin, IE

Sharon Cunningham(CEO & Co-Founder)Orlaith Ryan(CTO & Co-Founder)

Co-investorsSeroba Life SciencesEnterprise Ireland

SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring.

BiotechDeep TechHealthtechMedical DevicesPortola Valley, US

MARK DAHM(Executive Officer, Director)

BoardRICHARD DEATLEY(Director)ROBERT TERRY(Director)TJ DURNAN(Director)

Co-investorsIllumina Ventures

Strategic Partners A/S is a Danish company listed on Nasdaq Copenhagen that enters into strategic partnerships with businesses of significant potential, taking active ownership to create value.

Sector Agnostic

San Francisco, US

Michael Barber(Director)Philip Dur(Executive Officer, Director)Ashmi Shah(Executive Officer)Dean Stephens(Executive Officer, Director)Shahyan Currimbhoy(Executive Officer)Niraj Katwala(Executive Officer)

Co-investorsKaiser Permanente VenturesVantagePoint Capital PartnersSummit Partners

Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology.

BiotechDeep TechHealthtechMedical Devices

Eliane Schutte(Chief Executive Officer)

Co-investorsVI PartnersYsios CapitalEQT Life SciencesInvest-NL

Co-investorsAvoro Capital AdvisorsOberland CapitalSunstone Capital